PAT-DX3

N/A

Report date: 2025/01/03 15:31:48

Base Information

Drug NamePAT-DX3

Drug Alias NamePAT-DX3

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionDNA repair inhibitorsNeutrophil Extracellular Traps inhibitors

TargetsNeutrophil Extracellular Traps

Therapy Area/IndicationsAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisBrain Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesYale University

China Registration ClassN/A

Active CompaniesPatrys Ltd

Inactive CompaniesN/A

Active IndicationsAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisBrain Neoplasms

Inactive IndicationsN/A

ATC CodeN/A